The biotech company is testing an injectable treatment that helps people lose weight differently. Amgen's treatment, called MariTide, also appears to help patients keep weight off after they stop taking it.
Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or walls of the abdomen, and have received one to three prior lines of treatment, according to the FDA.
If the court restricts access to an abortion medication approved by the FDA, vaccines, birth control and other politically-charged therapies could be next.
Worries about cost and a lifetime of Ozempic-like treatments are driving patients to services that promise to wean them off without putting the pounds back on.